Class II · Moderate risk
Acyclovir Sodium Injection 1
Presence of Particulate Matter: Customer complaint of dark particles found inside the vial
FDA Drug Recalls
259 recalls · Class II, newest first
Class II · Moderate risk
Glycopyrrolate Tablets
Failed Impurities/Degradation Specifications
Class II · Moderate risk
0.9% Sodium Chloride Injection
Lack of Assurance of Sterility: Leakage of 0.9% Sodium Chloride for Injection, 1L, 12pk Saline Solution.
Class II · Moderate risk
Daytrana (methylphenidate transdermal system)
Defective Delivery System: Recalled lot was found to be out of specification for shear. Shear is an attribute related to the adhesive properties of the transdermal patches.
Class II · Moderate risk
0.9% Sodium Chloride Injection
Lack of assurance of sterility: Bags have the potential to leak in the flexible containers which may compromise sterility.
Class II · Moderate risk
Adam's Polishes ALCOHOL BASED HAND SANITIZER
CGMP Deviations: Other lots of hand sanitizer are being recalled because they were manufactured under the same conditions as the product lot found to contain methanol.
Class II · Moderate risk
Tobramycin Ophthalmic Solution
CGMP Deviations:
Class II · Moderate risk
Tobramycin Ophthalmic Solution
CGMP Deviations:
Class II · Moderate risk
Timolol Maleate Ophthalmic Solution
CGMP Deviations:
Class II · Moderate risk
Sodium Chloride Ophthalmic Ointment
CGMP Deviations:
Class II · Moderate risk
Proparacaine Hydrochloride Ophthalmic Solution
CGMP Deviations:
Class II · Moderate risk
Proparacaine Hydrochloride Ophthalmic Solution
CGMP Deviations:
Class II · Moderate risk
Class II · Moderate risk
Olopatadine HCl Ophthalmic Solution
CGMP Deviations:
Class II · Moderate risk
Olopatadine HCl Ophthalmic Solution
CGMP Deviations:
Class II · Moderate risk
Olopatadine HCl Ophthalmic Solution
CGMP Deviations:
Class II · Moderate risk
Olopatadine HCL Ophthalmic Solution
CGMP Deviations:
Class II · Moderate risk
Olopatadine HCl Ophthalmic Solution
CGMP Deviations:
Class II · Moderate risk
Ofloxacin Ophthalmic Solution
CGMP Deviations:
Class II · Moderate risk
Neomycin and Polymyxin B Sulfates
CGMP Deviations:
Class II · Moderate risk
Moxifloxacin Ophthalmic Solution
CGMP Deviations:
Class II · Moderate risk
Lidocaine Hydrochloride Jelly USP
CGMP Deviations:
Class II · Moderate risk
Levofloxacin Ophthalmic Solution 0.5%
CGMP Deviations:
Class II · Moderate risk
Ketorolac Tromethamine Ophthalmic Solution
CGMP Deviations:
Class II · Moderate risk
GONAK Hypromellose Ophthalmic Demulcent Solution
CGMP Deviations: